When to Hold Metformin and Jardiance for Surgery
Hold metformin on the day of surgery (morning of procedure) and discontinue Jardiance (empagliflozin) 3-4 days before surgery.
Jardiance (Empagliflozin) - SGLT2 Inhibitor
The most critical medication to hold early is Jardiance due to the risk of euglycemic diabetic ketoacidosis (euDKA), a life-threatening complication that can occur even with normal blood glucose levels.
Timing for Jardiance Discontinuation:
- Standard recommendation: 3-4 days before elective surgery 1
- This extended withholding period is necessary because SGLT2 inhibitors can have prolonged action and the risk of euDKA persists for several days after discontinuation 2
- Case reports document euDKA occurring even when held 54-151 hours preoperatively, particularly in high-risk patients 2
Risk Factors Requiring Extra Vigilance:
- Insulin-dependent diabetes
- Major surgery with prolonged fasting
- Emergency or semi-urgent procedures
- Hypovolemia or dehydration
- Infection or sepsis
- Hepatic or renal dysfunction 3
Critical pitfall: Euglycemic DKA presents with metabolic acidosis and ketones but blood glucose may be <250 mg/dL, making it easy to miss if you're only monitoring glucose 4. Monitor for signs of acidosis (nausea, vomiting, abdominal pain, altered mental status) even when glucose appears controlled.
Metformin
The most recent high-quality guideline (2025 ADA Standards of Care) recommends holding metformin on the day of surgery only 1, representing a significant shift from older recommendations.
Timing for Metformin Discontinuation:
- Current recommendation: Hold on the morning of surgery 1
- Older guidelines suggested holding the night before 5
- Historical recommendations of 48 hours prior are now considered overly conservative 6, 7
Rationale for Updated Timing:
The feared complication of metformin-associated lactic acidosis (MALA) is extremely rare (2-9 cases per 100,000 patients/year) and primarily occurs in patients with pre-existing risk factors, not from metformin itself 5. Recent evidence shows continuation until the night before surgery does not increase lactate levels or adverse outcomes in CABG patients 6.
Risk Factors That Warrant Caution:
- Renal impairment (creatinine clearance <60 mL/min) - most important risk factor 5
- Severe heart failure (LVEF <30%)
- Conditions causing dehydration or acute renal dysfunction
- Concurrent use of ACE inhibitors, ARBs, diuretics, or NSAIDs
- Administration of iodinated contrast agents
- Elderly patients (>65 years) on high doses (>2000 mg/day) 5
If these risk factors are present, consider holding metformin the night before surgery and do not restart for 48 hours post-major surgery until renal function is confirmed adequate 5.
Perioperative Blood Glucose Management
- Target perioperative glucose: 100-180 mg/dL (5.6-10.0 mmol/L) within 4 hours of surgery 1
- Do not use CGM alone for intraoperative glucose monitoring 1
- For minor/ambulatory procedures with minimal fasting, the risk-benefit calculation may differ, but the same withholding intervals apply for safety
Postoperative Restart
Jardiance:
- Restart only after:
- Patient is eating and drinking normally
- No signs of volume depletion
- No infection or metabolic stress
- Adequate renal function confirmed (eGFR ≥45 mL/min/1.73 m²) 4
Metformin:
- Can restart once oral intake resumes for minor surgery
- For major surgery: wait 48 hours and confirm adequate renal function 5
Key takeaway: The divergent timing (same-day hold for metformin vs. 3-4 days for Jardiance) reflects fundamentally different risk profiles - metformin's lactic acidosis risk is largely theoretical in patients without renal dysfunction, while Jardiance's euDKA risk is real, unpredictable, and potentially fatal even with normal glucose readings.